Partners in Discovery
Partners in Discovery
Vanderbilt-Ingram Cancer Center
Vanderbilt-Ingram Cancer Center is at the forefront of new discoveries that help us prevent, find, treat, manage and cure cancer. But we can't make these discoveries alone. Our patients, caregivers, community leaders, donors, volunteers, and educators contribute their insight, time, and passion to advancing the discoveries that lead us closer to a cure.
No matter how cancer has touched your life, you are a key partner in our efforts to save lives and improve the quality of life for those with cancer.
Harnessing the power of
science for our patients
Our doctors and researchers are turning today's
scientific discoveries into tomorrow's treatments.
Learn more about our research programs and initiatives.
Proven Track Record
A leader in research, innovation and treatment. We are one of 49 National Cancer Institute-designated Comprehensive Cancer Centers, dedicated to an integrated and patient-focused approach.
Patients, Partners, Progress
Our patients and families are our most important partners in discovery – and the motivation behind our efforts to advance research and improve cancer care.
Read their stories from Momentum magazine.
Cancer Center News
Latest news about our research, patient care programs, outreach and educational events.
Pal named to cancer research national leadership posts
Tuya Pal, MD, Ingram Professor of Cancer Research and associate director for Cancer Health Disparities at Vanderbilt-Ingram Cancer Center, has been named to two cancer research leadership posts.
Study reveals new strategy for reducing tumor growth, metastasis
Vanderbilt investigators has discovered that blocking a certain signaling pathway boosts antitumor immunity and reduces tumor growth and metastasis in models of breast cancer and melanoma.
Rini to lead NCI study of COVID-19 in cancer patients
Brian Rini, MD, is leading a study launched by the National Cancer Institute (NCI) that will closely monitor cancer patients who acquire COVID-19 with the goal of providing highly detailed data to guide future care.
Lovly to chair foundation’s scientific leadership board
Christine Lovly, MD, PhD, Ingram Associate Professor of Cancer Research, has been named incoming chair of GO2 Foundation’s Scientific Leadership Board (SLB).
Park named director of Hematology and Oncology at VICC
After serving as interim director since Jan. 1, Ben Ho Park, MD, PhD, has been named director of the Division of Hematology and Oncology.
‘Black in Cancer’ promotes diversity in research
Black In Cancer, an initiative cofounded by Henry Henderson III, PhD, a postdoctoral researcher at Vanderbilt-Ingram Cancer Center, is making an impact just two months after its inception.
